Literature DB >> 7969143

AML1 is expressed in skeletal muscle and is regulated by innervation.

X Zhu1, J E Yeadon, S J Burden.   

Abstract

Although most skeletal muscle genes are expressed at similar levels in electrically active, innervated muscle and in electrically inactive, denervated muscle, a small number of genes, including those encoding the acetylcholine receptor, N-CAM, and myogenin, are expressed at significantly higher levels in denervated than in innervated muscle. The mechanisms that mediate electrical activity-dependent gene regulation are not understood, but these mechanisms are likely to be responsible, at least in part, for the changes in muscle structure and function that accompany a decrease in myofiber electrical activity. To understand how muscle activity regulates muscle structure and function, we used a subtractive-hybridization and cloning strategy to identify and isolate genes that are expressed preferentially in innervated or denervated muscle. One of the genes which we found to be regulated by electrical activity is the recently discovered acute myeloid leukemia 1 (AML1) gene. Disruption and translocation of the human AML1 gene are responsible for a form of acute myeloid leukemia. AML1 is a DNA-binding protein, but its normal function is not known and its expression and regulation in skeletal muscle were not previously appreciated. Because of its potential role as a transcriptional mediator of electrical activity, we characterized expression of the AML1 gene in innervated, denervated, and developing skeletal muscle. We show that AML1 is expressed at low levels in innervated skeletal muscle and at 50- to 100-fold-higher levels in denervated muscle. Four AML1 transcripts are expressed in denervated muscle, and the abundance of each transcript increases after denervation. We transfected C2 muscle cells with an expression vector encoding AML1, tagged with an epitope from hemagglutinin, and we show that AML1 is a nuclear protein in muscle. AML1 dimerizes with core-binding factor beta (CBF beta), and we show that CGF beta is expressed at high levels in both innervated and denervated skeletal muscle. PEBP2 alpha, which is structurally related to AML1 and which also dimerizes with CBF beta, is expressed at low levels in skeletal muscle and is up-regulated only weakly by denervation. These results are consistent with the idea that AML1 may have a role in regulating gene expression in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969143      PMCID: PMC359343          DOI: 10.1128/mcb.14.12.8051-8057.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

Authors:  P Erickson; J Gao; K S Chang; T Look; E Whisenant; S Raimondi; R Lasher; J Trujillo; J Rowley; H Drabkin
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

2.  Neural regulation of N-cadherin gene expression in developing and adult skeletal muscle.

Authors:  C G Hahn; J Covault
Journal:  J Neurosci       Date:  1992-12       Impact factor: 6.167

3.  Leukaemia/Drosophila homology.

Authors:  A Daga; J E Tighe; F Calabi
Journal:  Nature       Date:  1992-04-09       Impact factor: 49.962

4.  Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs.

Authors:  A Duclert; J Piette; J P Changeux
Journal:  Neuroreport       Date:  1991-01       Impact factor: 1.837

Review 5.  Synaptic structure and development: the neuromuscular junction.

Authors:  Z W Hall; J R Sanes
Journal:  Cell       Date:  1993-01       Impact factor: 41.582

Review 6.  Synapse-specific gene expression.

Authors:  S J Burden
Journal:  Trends Genet       Date:  1993-01       Impact factor: 11.639

7.  Response of myogenic determination factors to cessation and resumption of electrical activity in skeletal muscle: a possible role for myogenin in denervation supersensitivity.

Authors:  C M Neville; M Schmidt; J Schmidt
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

8.  Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.

Authors:  S C Bae; Y Yamaguchi-Iwai; E Ogawa; M Maruyama; M Inuzuka; H Kagoshima; K Shigesada; M Satake; Y Ito
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

9.  Spatial restriction of AChR gene expression to subsynaptic nuclei.

Authors:  A M Simon; P Hoppe; S J Burden
Journal:  Development       Date:  1992-03       Impact factor: 6.868

10.  Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones.

Authors:  S M Hughes; J M Taylor; S J Tapscott; C M Gurley; W J Carter; C A Peterson
Journal:  Development       Date:  1993-08       Impact factor: 6.868

View more
  26 in total

1.  A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Authors:  R Yagi; L F Chen; K Shigesada; Y Murakami; Y Ito
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.

Authors:  K L Rhoades; C J Hetherington; J D Rowley; S W Hiebert; G Nucifora; D G Tenen; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  HOXA5 plays tissue-specific roles in the developing respiratory system.

Authors:  Kim Landry-Truchon; Nicolas Houde; Olivier Boucherat; France-Hélène Joncas; Jeremy S Dasen; Polyxeni Philippidou; Jennifer H Mansfield; Lucie Jeannotte
Journal:  Development       Date:  2017-08-21       Impact factor: 6.868

4.  Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.

Authors:  H Miyoshi; M Ohira; K Shimizu; K Mitani; H Hirai; T Imai; K Yokoyama; E Soeda; M Ohki
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

5.  Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye development.

Authors:  Kristina Jackson Behan; Jason Fair; Shalini Singh; Michael Bogwitz; Trent Perry; Vladimir Grubor; Fiona Cunningham; Charles D Nichols; Tara L Cheung; Philip Batterham; John Archie Pollock
Journal:  Dev Genes Evol       Date:  2005-05-03       Impact factor: 0.900

6.  A new hypothalamic polypeptide is a regulator of myelopoiesis.

Authors:  Armen A Galoyan; Vardan S Aprikyan
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

7.  A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype.

Authors:  Pernille Keller; Niels B J Vollaard; Thomas Gustafsson; Iain J Gallagher; Carl Johan Sundberg; Tuomo Rankinen; Steven L Britton; Claude Bouchard; Lauren G Koch; James A Timmons
Journal:  J Appl Physiol (1985)       Date:  2010-10-07

8.  Stretching and electrical stimulation reduce the accumulation of MyoD, myostatin and atrogin-1 in denervated rat skeletal muscle.

Authors:  Thiago L Russo; Sabrina M Peviani; João L Q Durigan; Davilene Gigo-Benato; Gabriel B Delfino; Tania F Salvini
Journal:  J Muscle Res Cell Motil       Date:  2010-02-27       Impact factor: 2.698

9.  NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.

Authors:  Stefan Gattenlöhner; Christiane Waller; Georg Ertl; Burkhard-Dieter Bültmann; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.

Authors:  Ophélie Philipot; Véronique Joliot; Ouardia Ait-Mohamed; Céline Pellentz; Philippe Robin; Lauriane Fritsch; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.